{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:47:35Z","timestamp":1785833255171,"version":"3.56.0"},"reference-count":49,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background: The use of hepatitis B surface antigen-positive (HBsAg+) kidneys may expand the donor pool for transplantation. This study evaluated the incidence, risk factors, complications, organ function, and survival outcomes of transplants from HBsAg+ donors to HBsAg\u2212 recipients. Methods: A systematic search of five databases was conducted through 20 August 2023. Incidence was expressed with 95% confidence intervals (CIs); odds ratios (ORs) and hazard ratios (HRs) assessed risk factors and survival. Results: Sixteen studies were included. Donor-derived HBV infection occurred in 3.60% (21\/583). Risk was higher in HBsAb-negative (OR: 6.67, 95% CI: 1.08\u201341.10) and HBcAb-negative recipients (OR: 12.96, 95% CI: 2.06\u201381.69). Abnormal liver function occurred in 35.18%, hepatitis in 3.07%, and hepatic failure in 0.84%. Liver and kidney function at 1\u20133 years were comparable between HBsAg+ and HBsAg\u2212 kidney recipients. Five- and ten-year graft survival (85.2%, 82.7%) and patient survival (93.0%, 91.4%) were similar to controls (p &gt; 0.05). Conclusions: HBsAg+ kidneys can achieve acceptable long-term outcomes with appropriate antiviral prophylaxis and cautious recipient selection, though infection risk requires careful assessment. These findings supports the cautious and selective use of HBsAg-positive kidneys in appropriately selected recipients use and standardized HBV prophylaxis.<\/jats:p>","DOI":"10.3390\/jcm15156048","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:02:19Z","timestamp":1785830539000},"page":"6048","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-Term Clinical Outcomes of Kidney Transplantation from Hepatitis B Surface Antigen (HBsAg)-Positive Donors to HBsAg-Negative Recipients: A Systematic Review and Meta-Analysis of Real-World Studies"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8896-1967","authenticated-orcid":false,"given":"Chengze","family":"Liang","sequence":"first","affiliation":[{"name":"Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu 610093, China"},{"name":"West China Medical School of Sichuan University, Chengdu 610093, China"},{"name":"Kidney Transplantation Center, West China Hospital, Sichuan University, Chengdu 610093, China"},{"name":"Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu 610093, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Luo","sequence":"additional","affiliation":[{"name":"Kidney Transplantation Center, West China Hospital, Sichuan University, Chengdu 610093, China"},{"name":"Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu 610093, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saifu","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu 610093, China"},{"name":"West China Medical School of Sichuan University, Chengdu 610093, China"},{"name":"Kidney Transplantation Center, West China Hospital, Sichuan University, Chengdu 610093, China"},{"name":"Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu 610093, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turun","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu 610093, China"},{"name":"Kidney Transplantation Center, West China Hospital, Sichuan University, Chengdu 610093, China"},{"name":"Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu 610093, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu 610093, China"},{"name":"Kidney Transplantation Center, West China Hospital, Sichuan University, Chengdu 610093, China"},{"name":"Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu 610093, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJMra2014530","article-title":"Long-Term Survival after Kidney Transplantation","volume":"385","author":"Hariharan","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.ajt.2023.02.004","article-title":"OPTN\/SRTR 2021 Annual Data Report: Kidney","volume":"23","author":"Lentine","year":"2023","journal-title":"Am. J. Transplant."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jhep.2022.03.007","article-title":"HBV-positive and HIV-positive organs in transplantation: A clinical guide for the hepatologist","volume":"77","author":"Russo","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/TP.0000000000001769","article-title":"KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors","volume":"101","author":"Lentine","year":"2017","journal-title":"Transplantation"},{"key":"ref_5","unstructured":"GBD 2019 Hepatitis B Collaborators (2022). Global, regional, and national burden of hepatitis B, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol. Hepatol., 7, 796\u2013829."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1097\/TP.0000000000002253","article-title":"British Transplantation Society\/Renal Association UK Guidelines for Living Donor Kidney Transplantation 2018: Summary of Updated Guidance","volume":"102","author":"Andrews","year":"2018","journal-title":"Transplantation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.16982","article-title":"OPTN\/SRTR 2020 Annual Data Report: Kidney","volume":"22","author":"Lentine","year":"2022","journal-title":"Am. J. Transplant."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.16502","article-title":"OPTN\/SRTR 2019 Annual Data Report: Kidney","volume":"21","author":"Hart","year":"2021","journal-title":"Am. J. Transplant."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cld.2021.06.009","article-title":"Use of Hepatitis B Virus-Positive Organs in Organ Transplantation","volume":"25","author":"Khemichian","year":"2021","journal-title":"Clin. Liver Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(94)90934-2","article-title":"\u201cOccult\u201d hepatitis B virus as source of infection in liver transplant recipients","volume":"343","author":"Mamish","year":"1994","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/TP.0b013e31824e3db4","article-title":"Hepatitis B-positive donors in renal transplantation: Increasing the deceased donor pool","volume":"94","author":"Pilmore","year":"2012","journal-title":"Transplantation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/SLA.0000000000005071","article-title":"Expanding the Donor Pool: First Use of Hepatitis B Virus Nat Positive Solid Organ Allografts Into Seronegative Recipients","volume":"274","author":"Delman","year":"2021","journal-title":"Ann. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e14466","DOI":"10.1111\/ctr.14466","article-title":"Influence of donor and recipient hepatitis B virus infection on long-term outcomes after kidney transplantation","volume":"35","author":"Yuan","year":"2021","journal-title":"Clin. Transplant."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/cid\/ciaa178","article-title":"Kidney Transplantation From Hepatitis B Surface Antigen (HBsAg)\u2013Positive Living Donors to HBsAg-Negative Recipients: Clinical Outcomes at a High-Volume Center in China","volume":"72","author":"Wang","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"390","DOI":"10.12659\/AOT.894073","article-title":"Assessment of Long-Term Outcomes in Hbs Ag-Negative Renal Transplant Recipients Transplanted from Hbs Ag-Positive Donors","volume":"20","author":"Kocak","year":"2015","journal-title":"Ann. Transplant."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.transproceed.2015.04.014","article-title":"Donors With Hepatitis B Surface Antigen Positivity","volume":"47","author":"Yavuz","year":"2015","journal-title":"Transplant. Proc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1111\/j.1600-6143.2005.01113.x","article-title":"HBsAg Seropositive Status and Survival After Renal Transplantation: Meta-Analysis of Observational Studies","volume":"5","author":"Fabrizi","year":"2005","journal-title":"Am. J. Transplant."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/0016-5085(91)70034-U","article-title":"Redevelopment of hepatitis B surface antigen after renal transplantation","volume":"100","author":"Marcellin","year":"1991","journal-title":"Gastroenterology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/ajt.13187","article-title":"Solid Organ Transplantation From Hepatitis B Virus\u2013Positive Donors: Consensus Guidelines for Recipient Management","volume":"15","author":"Huprikar","year":"2015","journal-title":"Am. J. Transplant."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/ki.2009.339","article-title":"Systematic reviews and meta-analyses: When they are useful and when to be careful","volume":"76","author":"Noordzij","year":"2009","journal-title":"Kidney Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Yin, S., Zhang, F., Wu, J., Lin, T., and Wang, X. (2023). Incidence, risk factors, and clinical outcomes of HBV reactivation in non-liver solid organ transplant recipients with resolved HBV infection: A systematic review and meta-analysis. PLoS Med., 20.","DOI":"10.1371\/journal.pmed.1004196"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/ajt.16248","article-title":"Risk factors for the development of invasive aspergillosis after kidney transplantation: Systematic review and meta-analysis","volume":"21","author":"Silva","year":"2021","journal-title":"Am. J. Transplant."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S2468-1253(22)00201-1","article-title":"Prevalence of occult hepatitis B virus infection in adults: A systematic review and meta-analysis","volume":"7","author":"Im","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e068769","DOI":"10.1136\/bmj-2021-068769","article-title":"Survival for waitlisted kidney failure patients receiving transplantation versus remaining on waiting list: Systematic review and meta-analysis","volume":"376","author":"Chaudhry","year":"2022","journal-title":"BMJ"},{"key":"ref_26","unstructured":"Wells, G.A., Shea, B., O\u2019Connell, D., Peterson, J., Welch, V., Losos, M., and Tugwell, P. (2024, July 15). The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Available online: www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin. Trials"},{"key":"ref_28","first-page":"1481","article-title":"Kidney transplantations with HBsAg+ donors","volume":"25","author":"Bedrossian","year":"1993","journal-title":"Transplant. Proc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/S0041-1345(97)00443-0","article-title":"Outcome of HBs antigen positive kidneys after renal transplantation","volume":"29","author":"Pageaux","year":"1997","journal-title":"Transplant. Proc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1016\/j.transproceed.2005.10.094","article-title":"The Effect of HBsAg-Positivity of Kidney Donors on Long-Term Patient and Graft Outcome","volume":"37","author":"Berber","year":"2005","journal-title":"Transplant. Proc."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.transproceed.2008.07.078","article-title":"HBsAg(+) Donor as a Kidney Transplantation Deceased Donor","volume":"40","author":"Wei","year":"2008","journal-title":"Transplant. Proc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/j.1600-6143.2009.02707.x","article-title":"Kidney Transplantation from Hepatitis B Surface Antigen Positive Donors into Hepatitis B Surface Antibody Positive Recipients: A Prospective Nonrandomized Controlled Study from a Single Center","volume":"9","author":"Jiang","year":"2009","journal-title":"Am. J. Transplant."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.transproceed.2008.09.056","article-title":"Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors","volume":"41","author":"Sumethkul","year":"2009","journal-title":"Transplant. Proc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.transproceed.2012.04.028","article-title":"Use of Kidney Donors with Hepatitis B, Hepatitis C, or Brain Tumor: A Single-Center Experience","volume":"44","author":"Tatar","year":"2012","journal-title":"Transplant. Proc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.transproceed.2012.04.015","article-title":"Hepatitis B Surface Antigen Positivity Is Not a Contraindication for Living Kidney Donation","volume":"44","author":"Tuncer","year":"2012","journal-title":"Transplant. Proc."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1111\/ajt.12921","article-title":"The Outcomes of Kidney Transplantation in Hepatitis B Surface Antigen (HBsAg)\u2013Negative Recipients Receiving Graft From HBsAg-Positive Donors: A Retrospective, Propensity Score-Matched Study","volume":"14","author":"Chancharoenthana","year":"2014","journal-title":"Am. J. Transplant."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12879-020-05704-1","article-title":"Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1111\/liv.15703","article-title":"Expanding the donor pool: Kidney transplantation from serum HBV DNA or HBeAg-positive donors to HBsAg-negative recipients","volume":"43","author":"Yin","year":"2023","journal-title":"Liver Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/liv.13498","article-title":"Spectrum of hepatitis B and renal involvement","volume":"38","author":"Shah","year":"2018","journal-title":"Liver Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00007890-199501270-00014","article-title":"The risk of transmission of hepatitis B from HBsAg(\u2212), HBcAb(+), HBIgM(\u2212) organ donors","volume":"59","author":"Wachs","year":"1995","journal-title":"Transplantation"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1097\/TP.0000000000003106","article-title":"Novel Organ Perfusion and Preservation Strategies in Transplantation\u2014Where Are We Going in the United Kingdom?","volume":"104","author":"Srinivasa","year":"2020","journal-title":"Transplantation"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2017). EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J. Hepatol., 67, 370\u2013398.","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"772","DOI":"10.2215\/CJN.04750416","article-title":"Immunogenicity of Augmented Compared With Standard Dose Hepatitis B Vaccine in Pediatric Patients on Dialysis: A Midwest Pediatric Nephrology Consortium Study","volume":"12","author":"Misurac","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.vaccine.2016.12.032","article-title":"Response to active hepatitis B vaccination and mortality in incident dialysis patients","volume":"35","author":"Zitt","year":"2017","journal-title":"Vaccine"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/j.ajkd.2009.03.010","article-title":"Intradermal Versus Intramuscular Hepatitis B Vaccination in Hemodialysis Patients: A Prospective Open-Label Randomized Controlled Trial in Nonresponders to Primary Vaccination","volume":"54","author":"Barraclough","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1473-3099(15)00218-2","article-title":"Seroepidemiology of hepatitis B virus infection in 2 million men aged 21\u201349 years in rural China: A population-based, cross-sectional study","volume":"16","author":"Liu","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/0140-6736(92)91530-L","article-title":"Hepatitis B virus and apparent fulminant non-A, non-B hepatitis","volume":"339","author":"Wright","year":"1992","journal-title":"Lancet"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.cmi.2018.02.003","article-title":"ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: An infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52)","volume":"24","author":"Mikulska","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e046293","DOI":"10.1136\/bmjopen-2020-046293","article-title":"Efficacy and safety of stratified versus routine prophylaxis in living kidney transplantation from HBsAg+ donors to HBsAg\u2212 recipients: Protocol for a multicentre, prospective, observational study","volume":"11","author":"Wang","year":"2021","journal-title":"BMJ Open"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/15\/6048\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:36:28Z","timestamp":1785832588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/15\/6048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":49,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcm15156048"],"URL":"https:\/\/doi.org\/10.3390\/jcm15156048","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]}}}